Basal Cell Carcinoma: From the Molecular Understanding of the Pathogenesis to Targeted Therapy of Progressive Disease
2011

Understanding Basal Cell Carcinoma and Its Treatment

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): Göppner Daniela, Leverkus Martin

Primary Institution: Otto-von-Guericke-University Magdeburg and Ruprecht-Karls-University of Heidelberg

Hypothesis

The Hedgehog (HH) pathway is a key factor in the development of basal cell carcinoma (BCC).

Conclusion

The study highlights the importance of the Hedgehog pathway in BCC development and the potential of targeted therapies.

Supporting Evidence

  • The Hedgehog pathway is implicated in about 25% of all cancers.
  • New HH inhibitors have shown promising results in treating advanced BCC.
  • Over 80% of BCC cases occur in sun-exposed areas.

Takeaway

Basal cell carcinoma is a common skin cancer linked to a specific pathway in the body, and new treatments are being developed to target this pathway.

Methodology

The paper reviews existing literature on BCC, focusing on its molecular pathogenesis and treatment options.

Limitations

The study lacks detailed information on dosage, side effects, and long-term outcomes of new therapies.

Participant Demographics

The study discusses BCC in individuals of fair complexion, particularly Caucasians, with a higher incidence in men and older adults.

Digital Object Identifier (DOI)

10.1155/2011/650258

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication